Naviscan, Inc., the leader in 3D Molecular Breast Imaging (MBI), has entered into a distribution agreement with Tecnologie Avanzate s.r.l. to market and service Naviscan's high-resolution organ-specific PET scanner in Italy. The agreement represents the introduction of PEM (Positron Emission Mammography), the scanner's breast application, as a new tool available to Italian women in their fight against breast cancer.
Naviscan manufactures the only commercially-available PEM scanner and PEM-guided biopsy system. The scanner uses PET technology to produce tomographic images that allow physicians to visualize breast tumors down to 2 mm, the width of a grain of rice. In recently published data, PEM has been found to be significantly more precise at identifying benign and cancerous lesions, in what scientists call "specificity", therefore reducing the number of unnecessary biopsies. This finding is a welcomed outcome for women and physicians looking for ways to reduce the patient trauma and cost associated with unnecessary procedures.
Tecnologie Avanzate and its partners have specialized in high tech medical equipment in the fields of nuclear imaging, radiation therapy and breast imaging since 1959 and is the exclusive distributor for Hologic® and TomoTherapy® products. The Naviscan PET scanner is an ideal complement to Tecnologie Avanzate's breast and nuclear imaging expertise and an ideal partner to continue its expansion in Europe.